Trademark247.com - Trademark Search Results

Showing 1-20 of 44 results

Mark Name	Mark Description
DERMAGEN Owned by: OSIRIS THERAPEU... Filed on: 06-18-1999 Status: Abandoned-No Statement of...	Pharmaceutical preparation for use in the partial or complete differentiation of mesenchymal progenitor cells or partially differentiation mesen	View Details Monitor Mark Create New Watchlist
DERMAGEN Owned by: OSIRIS THERAPEU... Filed on: 03-14-1995 Status: Abandoned-No Statement of...	pharmaceutical preparations for use in the partial or complete differentiation of mesenchymal progenitor cells or partially differentiated mesen	View Details Monitor Mark Create New Watchlist
Owned by: OSIRIS THERAPEU... Filed on: 12-13-2005 Status: Abandoned-Failure to Resp...	Cells for medical use for regeneration of human tissue, namely, bone, cartilage, marrow, muscle, adipose, tissue and tendon	View Details Monitor Mark Create New Watchlist
Owned by: OSIRIS THERAPEU... Filed on: 07-18-2000 Status: Cancelled-Section 8	Cells for medical use for regeneration of human connective tissue, namely, bone, cartilage, marrow, muscle, adipose and tendon	View Details Monitor Mark Create New Watchlist
STROMAGENIX Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	formulations of stromal forming cells and a biodegradable materials which form new stromal tissue in vivo	View Details Monitor Mark Create New Watchlist
ADIPOGEN Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	chemical or biological agents which cause progenitor cells to be differentiated into fat tissue lineage cells for medical use	View Details Monitor Mark Create New Watchlist
PRESTIGE LYOTECHNOLOGY Owned by: OSIRIS THERAPEU... Filed on: 06-08-2018 Status: Abandoned-No Statement of...	Lyopreservation of human tissue Processing of human tissue with viable cells for medical purposes	View Details Monitor Mark Create New Watchlist
CHRONDROREGENIX Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	formulations of cartilage forming cells and a biodegradable matrix which form new cartilage tissue in vivo	View Details Monitor Mark Create New Watchlist
OSTEOPROGENIX Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	formulations of bone forming cells and biodegradable materials which form new bone tissue in vivo	View Details Monitor Mark Create New Watchlist
DERMANEXIN Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	chemical or biological agents for medical use which cause tissue-forming progenitor cells to commit into or produce differentiated dermis tissue	View Details Monitor Mark Create New Watchlist
ADIPOPOIETIN Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	pharmaceuticals preparations for use in the partial or complete differentiation of mesenchymal progenitor cells or partially differentiated mese	View Details Monitor Mark Create New Watchlist
ASTROSTEM Owned by: OSIRIS THERAPEU... Filed on: 01-17-2002 Status: Abandoned-No Statement of...	Cells for medical use, namely, for the treatment of neural injury and deficit	View Details Monitor Mark Create New Watchlist
NEURORESTORATIVE THERAPY Owned by: OSIRIS THERAPEU... Filed on: 04-23-1999 Status: Abandoned-Failure to Resp...	MESENCHYMAL STEM CELLS AND CELLS AND TISSUES DIFFERENTIATED THEREFROM FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS	View Details Monitor Mark Create New Watchlist
PROMESYN Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-Failure to Resp...	chemical or biological agents for medical use which cause tissue-forming progenitor cells to proliferate in vitro or in vivo	View Details Monitor Mark Create New Watchlist
ADIPONEXIN Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	chemical or biological agents which cause tissue-forming progenitor cells to commit into or produce differentiated adipose tissue in vitro or in	View Details Monitor Mark Create New Watchlist
CHONDRONEXIN Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	chemical or biological agents for medical use which cause tissue-forming progenitor cells to commit into or produce differentiated cartilage tis	View Details Monitor Mark Create New Watchlist
REGENERATIVE MEDICINE Owned by: OSIRIS THERAPEU... Filed on: 05-10-1999 Status: Abandoned-Failure to Resp...	MESENCHYMAL STEM CELLS	View Details Monitor Mark Create New Watchlist
MESENZYME Owned by: OSIRIS THERAPEU... Filed on: 11-20-2003 Status: Abandoned-No Statement of...	PHARMACEUTICAL PREPARATIONS, NAMELY, GENETICALLY ENGINEERED MESENCHYMAL STEM CELLS FOR THE SECRETION OF ENZYMES	View Details Monitor Mark Create New Watchlist
MESENZYME Owned by: OSIRIS THERAPEU... Filed on: 08-25-1999 Status: Abandoned-No Statement of...	pharmaceutical preparations, namely, genetically engineered mesenchymal stem cells for the secretion of enzymes	View Details Monitor Mark Create New Watchlist
CHONDRIX Owned by: OSIRIS THERAPEU... Filed on: 07-30-1996 Status: Abandoned-No Statement of...	formulations of cartilage forming cells and a biodegradable matrix which form new cartilage tissue in vivo	View Details Monitor Mark Create New Watchlist

Preparing summary view, please wait...

Owner Summary

This report includes a summary of your search results. The 'Marks Matched' column indicates the number of results that match a particular trademark owner, It does not include all of their other marks.

Primary Classification Summary

Status Summary

File Year Summary

Registration Statistics

Quick Links

Updated Daily